Rickard Kathleen A. — SEC Form 4 filings
SEC reporting owner CIK 1836883. 15 Form 4 filings on record with FilingPulse; latest filed 2025-10-08.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-05 to 2025-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 8 filings — 648,664 shares, $4,520,048 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: sale of 240,000 shares @ $4.90 ($1,176,360) in Verona Pharma plc, filed 2024-11-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) | Chief Medical Officer | 15 | — | 9 legs · 648,664 sh · $4,520,048 | 34 |
Form 4 filings — Rickard Kathleen A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-08 | 4 | Verona Pharma plc (VRNA) | Disposition to issuer (D): 2,432,868 · Option exercise (M): 1,131,984 · Disposition to issuer (D): 1,131,984 · Option exercise (M): 146,168 (derivative) · Option exercise (M): 167,056 (derivative) · Option exercise (M): 200,000 (derivative) · +4 more | EDGAR |
| 2025-09-03 | 4 | Verona Pharma plc (VRNA) | Gift (G): 189,600 @ $0 | EDGAR |
| 2025-08-05 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 70,888 @ $0 · Sale (S): 58,336 @ $13.14 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 20,888 (derivative) @ $0 | EDGAR |
| 2025-07-09 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 86,064 @ $0 · Tax withholding (F): 37,616 @ $11.44 · Grant/award (A): 253,120 (derivative) @ $0 · Option exercise (M): 86,064 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | Verona Pharma plc (VRNA) | Sale (S): 114,984 @ $8.82 | EDGAR |
| 2025-05-05 | 4 | Verona Pharma plc (VRNA) | Sale (S): 27,336 @ $8.95 · Option exercise (M): 50,000 · Sale (S): 21,864 @ $8.95 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 86,064 @ $0 · Sale (S): 34,384 @ $8.98 · Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 253,120 (derivative) @ $0 · Option exercise (M): 86,064 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Verona Pharma plc (VRNA) | Sale (S): 79,264 @ $8.35 | EDGAR |
| 2025-02-04 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 50,000 @ $0 · Tax withholding (F): 33,240 @ $7.16 | EDGAR |
| 2024-11-26 | 4 | Verona Pharma plc (VRNA) | Sale (S): 240,000 @ $4.90 | EDGAR |
| 2024-11-01 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 300,000 @ $0 · Grant/award (A): 50,000 @ $0 · Tax withholding (F): 65,936 @ $4.24 | EDGAR |
| 2024-08-09 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 200,000 @ $0 · Tax withholding (F): 87,904 @ $2.62 | EDGAR |
| 2024-08-05 | 4 | Verona Pharma plc (VRNA) | Tax withholding (F): 106,232 @ $2.83 | EDGAR |
| 2024-05-03 | 4 | Verona Pharma plc (VRNA) | Tax withholding (F): 73,824 @ $1.93 · Sale (S): 36,248 @ $1.96 | EDGAR |
| 2024-02-05 | 4 | Verona Pharma plc (VRNA) | Tax withholding (F): 72,768 @ $2.29 · Sale (S): 36,248 @ $2.22 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1836883 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →